QbD & PAT conference will bring together participants from industry, academia and regulatory creating invaluable opportunity to discuss the recent developments, future trends, challenges and Solutions for development & Manufacturing of Pharmaceutical & Biotechnology products.The conference will focus on discussing the existing challenges and explore practical applications related to drug development, manufacturing and regulatory. Its a 2 day program which will include presentations, talks, case studies, panel & Round-table discussions from industry leaders, solution providers and academia.
The Day 2 will be dedicated to training/workshop. Below are few benefits of attending our conference.
Jeff Duke has over 20 years of pharmaceuticals industry experience in both human and veterinary health in a wide range of Chemistry, Manufacturing and Control functions. Prior to becoming an independent consultant, Jeff held senior positions within Pfizer such as Executive Director European Analytical Research & Development, Head of Strategy & Implementation for Pharmaceutical Sciences Asia Business Development, ‘ Head of Global Material Science and Oral Products as well as Director, European Analytical R&D Full Development. Jeff was involved in bringing 6 NCE drugs to the market. As a consultant Jeff provides training, consultancy and interim management services in the following areas: CMC Strategy Development, including Quality by Design (QbD). Release testing strategies drug products and API, Analytical method development, validation and inter laboratory method transfer, Integration of API & Drug Product strategies through development of Materials Science approaches
Bioprocess ConsultingROK Consulting UK
Dr.O'Kennedy has over twenty years of experience in the biopharmaceutical sector having worked in academia and for large biopharmaceutical companies and CMOs. Dr.O'Kennedy started his career at the Dept of Biochemical Engineering in UCL as a Post Doc researcher focused on Plasmid DNA vaccines. He joined the GSK Bioprocess Development Group in Beckenham in 2000. At GSK, he focused on upstream development of mammalian cell culture & microbial processes for clinical manufacture, process monitoring & control and technical transfer of processes into clinical manufacturing of MAbs and DNA vaccines. In 2009, he joined the Department of Chemical Engineering at Newcastle Uiversity providing a biopharmaceutical industry focus to the Biopharmaceutical Bioprocessing Technology Center. In 2011, Dr.O'Kennedy moved to Fujifilm Diosynth Botechnologies(FDB) R&D where he was Head of Mammalian Cell Culture Process Development. His group focused on developent of mammalian cell culture based bioprocesses for manufacture of MAbs and biotherapeutic drugs.
Maximise Your Involvement: Sponsorship and Exhibition Opportunities
Scientists, Manager & Senior Managers in the pharmaceutical & Biotechnology Industry, both in R&D and Contract Research & Manufacturing, particularly in the following areas
Quality Assurance Personnel and Quality control Personnel
Product Specialist and Process Development Analyst
Compliance Process Analytics
Manufacturing Manager R&D Manager
Memories from the QbD&PAT Conference 2017 India.